abstract |
Molecule biospecifies linking TLR9 and CD32 and understanding a T cell epitope for the treatment of allergies. The present invention relates to a molecule or complex of molecules capable of binding to TLR9 and CD32 comprising at least one epitope of at least one antigen, its production and use as a medicament, especially for the treatment of allergies. |